INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
DI

Delaet Ingrid

Chief Regulatory OfficerCIK 0001965808

EDGAR filingsOpen in network
Disclosed transactions18
Buys / sells0 / 1
Max Insider Score30
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award
A—
4,483 sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    NEUROCRINE BIOSCIENCES INCChief Regulatory Officer · Feb 17, 2026
15
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Tax withholding
F
$378K
2,419 sh
Sep 11, 2026
Sep 15, 2026
traded Sep 11, 2026
+4d
SEC FORM 4

Evidence

0
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
2,261 sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC FORM 4

Evidence

6
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Option exercise · 10b5-1 plan
M$179K
2,261 sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC FORM 4

Evidence

25
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Open-market sale · 10b5-1 plan
SELL$354K
2,261 sh
May 29, 2026Jun 2, 2026
traded May 29, 2026
+4dSEC FORM 4

Evidence

16
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Tax withholding
F$91K
734 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence

21
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award
A—
19.9K sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence

30
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Tax withholding
F$1.33M
10.8K sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence

21
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Option exercise
M—
1,401 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence

9
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award
A—
31.2K sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence

23
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Option exercise
M—
1,600 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

22
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Tax withholding
F$108K
881 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

17
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Option exercise
M—
1,359 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence

9
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Option exercise
M—
1,359 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence

23
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Option exercise
M—
1,600 sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC FORM 4

Evidence

9
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award
A—
5,479 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence

17
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Option exercise
M—
1,401 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence

16
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Tax withholding
F$94K
756 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC FORM 4

Evidence